CYP450 Genotype—Phenotype Concordance Using the Geneva Micrococktail in a Clinical Setting
Pharmacokinetic variability is a major source of differences in drug response and can be due to genetic variants and/or drug-drug interactions. Cytochromes P450 are among the most studied enzymes from a pharmacokinetic point of view. Their activity can be measured by phenotyping, and/or predicted by...
Main Authors: | Kuntheavy Ing Lorenzini, Jules Desmeules, Victoria Rollason, Stéphane Bertin, Marie Besson, Youssef Daali, Caroline F. Samer |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.730637/full |
Similar Items
-
Psychoactive Medication, Violence, and Variant Alleles for Cytochrome P450 Genes
by: Selma J. M. Eikelenboom-Schieveld, et al.
Published: (2021-05-01) -
Evaluation of Phenotypic and Genotypic Variations of Drug Metabolising Enzymes and Transporters in Chronic Pain Patients Facing Adverse Drug Reactions or Non-Response to Analgesics: A Retrospective Study
by: Victoria Rollason, et al.
Published: (2020-10-01) -
Chronic Inflammatory Status Observed in Patients with Type 2 Diabetes Induces Modulation of Cytochrome P450 Expression and Activity
by: Lucy Darakjian, et al.
Published: (2021-05-01) -
“Late” Withdrawal Syndrome after Carbamazepine In Utero Exposure in a CYP2C9 Slow Metabolizer Newborn
by: Caroline F. Samer, et al.
Published: (2017-04-01) -
Rivaroxaban-induced hemorrhage associated with ABCB1 genetic defect
by: Kuntheavy Ing Lorenzini, et al.
Published: (2016-12-01)